[go: up one dir, main page]

ZA9710643B - 5-cyclo indole compounds - Google Patents

5-cyclo indole compounds

Info

Publication number
ZA9710643B
ZA9710643B ZA9710643A ZA9710643A ZA9710643B ZA 9710643 B ZA9710643 B ZA 9710643B ZA 9710643 A ZA9710643 A ZA 9710643A ZA 9710643 A ZA9710643 A ZA 9710643A ZA 9710643 B ZA9710643 B ZA 9710643B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
optionally substituted
membered
independently selected
ht1d
Prior art date
Application number
ZA9710643A
Other languages
English (en)
Inventor
Abdelmalik Slassi
Louise Edwards
Qingchang Meng
Sumanas Rakhit
Original Assignee
Allelix Biopharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharma filed Critical Allelix Biopharma
Publication of ZA9710643B publication Critical patent/ZA9710643B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
  • Hybrid Cells (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
ZA9710643A 1996-11-26 1997-11-26 5-cyclo indole compounds ZA9710643B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75580596A 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
ZA9710643B true ZA9710643B (en) 1998-09-02

Family

ID=25040731

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9710643A ZA9710643B (en) 1996-11-26 1997-11-26 5-cyclo indole compounds

Country Status (11)

Country Link
EP (1) EP0944595B1 (fr)
JP (1) JP2001504501A (fr)
CN (1) CN1289479C (fr)
AT (1) ATE251136T1 (fr)
AU (1) AU738668B2 (fr)
CA (1) CA2273328C (fr)
DE (1) DE69725337T2 (fr)
ES (1) ES2208955T3 (fr)
TW (1) TW432059B (fr)
WO (1) WO1998023587A1 (fr)
ZA (1) ZA9710643B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100291A (en) * 1998-03-16 2000-08-08 Allelix Biopharmaceuticals Inc. Pyrrolidine-indole compounds having 5-HT6 affinity
US6251893B1 (en) * 1998-06-15 2001-06-26 Nps Allelix Corp. Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
US6329390B1 (en) * 1998-07-17 2001-12-11 Nps Allelix Corp. 5-Bicycloindole compounds
US6562809B1 (en) * 1998-09-18 2003-05-13 Nps Allelix Corp. 3-bicycloindole compounds
US6380242B1 (en) * 1998-12-23 2002-04-30 Nps Allelix Corp. N-alkylamino-indoles for the treatment of migraine
CN1281605C (zh) * 2000-12-22 2006-10-25 惠氏公司 作为5-羟色胺-6配基的杂环基-吲唑或氮杂吲唑化合物
EP1803720A1 (fr) * 2000-12-22 2007-07-04 Wyeth a Corporation of the State of Delaware Composes Heterocyclylindazole et Azaindazole utilises en tant que ligands 5-Hydroxytryptamine-6
JP2006517966A (ja) 2003-02-14 2006-08-03 ワイス 5−ヒドロキシトリプタミン−6リガンドとしてのヘテロサイクリル−3−スルホニルアザインドールまたは−アザインダゾール誘導体
US8030257B2 (en) 2005-05-13 2011-10-04 Exxonmobil Research And Engineering Company Catalytic antioxidants
CN102936240A (zh) * 2012-10-30 2013-02-20 浙江省医学科学院 一种(r)-5-取代-3-(n-苄氧羰基吡咯烷-2-基羰基)-1h-吲哚的合成方法
CN107698558B (zh) * 2017-10-24 2019-04-02 温州大学 一种氮杂环硫化物的制备方法及其净化提纯方法
JP2021505555A (ja) * 2017-12-01 2021-02-18 タイワンジェ ファーマシューティカルズ カンパニー リミテッドTaiwanj Pharmaceuticals Co., Ltd. ベンゼン縮合複素環化合物およびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833153A (en) * 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB9226537D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5300645A (en) * 1993-04-14 1994-04-05 Eli Lilly And Company Tetrahydro-pyrido-indole
JP2802169B2 (ja) * 1993-04-22 1998-09-24 ファイザー・インコーポレーテッド 片頭痛に用いる5−ht▲下1▼様アゴニストとしてのインドール誘導体

Also Published As

Publication number Publication date
EP0944595A1 (fr) 1999-09-29
CA2273328C (fr) 2009-04-28
WO1998023587A1 (fr) 1998-06-04
CA2273328A1 (fr) 1998-06-04
AU5112298A (en) 1998-06-22
DE69725337T2 (de) 2004-07-15
AU738668B2 (en) 2001-09-20
TW432059B (en) 2001-05-01
ATE251136T1 (de) 2003-10-15
CN1245491A (zh) 2000-02-23
HK1026689A1 (en) 2000-12-22
CN1289479C (zh) 2006-12-13
DE69725337D1 (de) 2003-11-06
ES2208955T3 (es) 2004-06-16
EP0944595B1 (fr) 2003-10-01
JP2001504501A (ja) 2001-04-03

Similar Documents

Publication Publication Date Title
ZA9710643B (en) 5-cyclo indole compounds
BR0013427A (pt) Compostos heteropolicìclicos e seus usos como antagonistas no receptor de glutamato metabotrópico
DK5389D0 (da) Substituerede pyrroler, pyrazoler og triazoler, fremgangsmaader til deres fremstilling samt deres anvendelse som angiotensin ii-antagonister
AU640417B2 (en) Substituted 5-((tetrazolyl)alkenyl)imidazoles
SE8503680D0 (sv) Indolderivat
ATE260910T1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep)
NO962539L (no) 5-(2-imidazolinylamino)benzimidazol-derivater, deres fremstilling og deres anvendelse som -2-adreniceptor-agonister
DK441187D0 (da) Alfa-alkyl-4-amino-3-quinolinmethanoler og 1-(4-aralkylamino-3-quinolinyl)alkanoner, deres fremstilling og anvendelse
ATE119524T1 (de) Substituierte n-(imidazolyl)alkyl-alanin- derivate.
PT1189923E (pt) Derivados aromaticos e heterociclicos de fitosterois e/ ou fitostanois para utilizacao no tratamento ou prevencao de doenca cardiovascular
DK0526313T3 (da) Nye ureaderivater, deres fremstilling og terapeutiske anvendelse
TR199902094T2 (xx) 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri.
ATE148103T1 (de) Aromatische hydroxyamidin-derivate und ihre verwendung als leukotriene-b4-rezeptor antagonisten
AU547319B2 (en) 1-(3-halo-2-pyridinyl) piperazine
DK613687D0 (da) Kondenserede heterocycliske tetrahydroaminoquinolinoler og beslaegtede forbindelser, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
KR950002761A (ko) 강박 반응 장애 치료제 제조용으로서의 n-(피리디닐)-1h-인돌-1-아민의 용도
NO902813L (no) (1,2,3,4-tetrahydro-9-acridinimino)cykloheksankarboksylsyre og relaterte forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter.
ATE243695T1 (de) 5-bicycloindolverbindungen
DK0725776T3 (da) 3-Aryl-4-alkyl- og 4,5-dialkyl-4H-1,2,4-triazoler anvendelige som hukommelsesforbedrende midler
DK571989D0 (da) Hydroxy-1,2,3,4-tetrahydroaminoacridiner, deres fremstilling og anvendelse
DE69114404D1 (de) 1-(Pyridinylalkyl)-1H-indole, -indoline und Analoge.
DK423186A (da) Spiro-(benzofuran-2(3h),1`cycloheptan)-derivater, deres fremstilling og anvendelse samt mellemprodukt til fremstillingen
DK114386D0 (da) Benzo(c)-1,5-naphthyridiner, fremgangsmaade og mellemprodukter til fremstilling deraf og deres anvendelse som laegemidler
NO932002L (no) Nye tiosemikarbazonsyreestere
DK0401779T3 (da) 4,5,5a,6-Tetrahydro-3H-isoazolo(5,4,3-kl)acridinderivater, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler